Search details
1.
Safety, tolerability and appropriate use of nintedanib in idiopathic pulmonary fibrosis.
Respir Res
; 16: 116, 2015 Sep 24.
Article
in English
| MEDLINE | ID: mdl-26400368
2.
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
Future Oncol
; 10(2): 219-31, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24490608
3.
A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 79(1): 17-27, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-27872953
4.
A phase II study of afatinib, an irreversible ErbB family blocker, added to letrozole in patients with estrogen receptor-positive hormone-refractory metastatic breast cancer progressing on letrozole.
Springerplus
; 5: 45, 2016.
Article
in English
| MEDLINE | ID: mdl-26835225
5.
Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer.
Clin Cancer Res
; 21(12): 2737-44, 2015 Jun 15.
Article
in English
| MEDLINE | ID: mdl-25370464
Results
1 -
5
de 5
1
Next >
>>